本季度信息
根据公司公告，云康集团预计2025财年（截至2025年12月31日）实现净利润介于0.032亿元至0.098亿元之间，而上一财年同期净亏损约为7.932亿元。公司方面表示，收入虽同比下降，但降幅逐步收窄，主要受集采、医保控费及行业竞争加剧等因素影响。与此同时，通过对客户与产品结构的优化，以及在诊断检测服务方面为医联体提供深度赋能，公司整体经营效率获得稳步改善。
公告显示，集团销售及行政开支均有所减少，主要得益于一系列精益管理措施与内部资源的精准投放；同时积极优化债务结构，财务成本也同比下降。在现金流方面，公司强调持续加强应收账款管理并缩短回款周期，部分前期计提的信用减值亏损得以撥回，有效改善整体经营现金流。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.